Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population

Shamira A Perera,1–3 Daniel SW Ting,1,2 Monisha E Nongpiur,1–3 Paul T Chew,3 Maria Cecilia D Aquino,3 Chelvin CA Sng,3 Sue-Wei Ho,1,2 Tin Aung1–3 1Singapore Eye Research Institute, Singapore; 2Singapore National Eye Centre, Singapore; 3Department of Ophthalmology, Yong...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Perera SA, Ting DSW, Nongpiur ME, Chew PT, Aquino MCD, Sng CCA, Ho SW, Aung T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/cf4746c7dc064d499a05bfedfcd92e62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cf4746c7dc064d499a05bfedfcd92e62
record_format dspace
spelling oai:doaj.org-article:cf4746c7dc064d499a05bfedfcd92e622021-12-02T03:14:47ZFeasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population1177-5483https://doaj.org/article/cf4746c7dc064d499a05bfedfcd92e622016-04-01T00:00:00Zhttps://www.dovepress.com/feasibility-study-of-sustained-release-travoprost-punctum-plug-for-int-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Shamira A Perera,1–3 Daniel SW Ting,1,2 Monisha E Nongpiur,1–3 Paul T Chew,3 Maria Cecilia D Aquino,3 Chelvin CA Sng,3 Sue-Wei Ho,1,2 Tin Aung1–3 1Singapore Eye Research Institute, Singapore; 2Singapore National Eye Centre, Singapore; 3Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Purpose: To investigate the efficacy and safety of a punctum plug-based sustained drug release system for a prostaglandin analog, travoprost (OTX-TP), for intraocular pressure (IOP) ­reduction in an Asian population. Methods: This is an initial feasibility, prospective, single-arm study involving 26 eyes and a bioresorbable punctum plug containing OTX-TP. An OTX-TP was placed in the vertical portion of the superior or inferior canaliculus of patients with primary open-angle glaucoma or ocular hypertension. The main outcome measure was the IOP-lowering efficacy of OTX-TP at 3 (8 am) and 10, 20, and 30 days (8 am, 10 am, and 4 pm), compared to baseline. Results: A total of 26 OTX-TP were inserted for 17 subjects. The mean (standard deviation) age was 57.2 (13.8) years. At 10 days, all plugs were still present, and the IOP reduction from baseline was 6.2 (23%), 5.4 (21%), and 7.5 mmHg (28%) at 8 am, 10 am, and 4 pm, respectively. At 10 days, the mean IOP (standard error of mean) was 21.2 (1.2), 20.4 (0.8), and 19.7 (1.0) at 8 am, 10 am, and 4 pm, respectively, showing no discernible IOP trend during the course of the day. At 30 days, plug retention had declined to 42%, and the overall IOP reduction had decreased to 16%. Conclusion: The sustained-release OTX-TP is able to reduce IOP by 24% (day 10) and 15.6% (day 30), respectively. It is a potentially well-tolerable ocular hypotensive for glaucoma patients with a history of poor compliance. Keywords: ocular hypertension, travoprost, bioresorbable, punctum plug, glaucoma, AsianPerera SATing DSWNongpiur MEChew PTAquino MCDSng CCAHo SWAung TDove Medical PressarticleTravoprostPunctum PlugOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 757-764 (2016)
institution DOAJ
collection DOAJ
language EN
topic Travoprost
Punctum Plug
Ophthalmology
RE1-994
spellingShingle Travoprost
Punctum Plug
Ophthalmology
RE1-994
Perera SA
Ting DSW
Nongpiur ME
Chew PT
Aquino MCD
Sng CCA
Ho SW
Aung T
Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
description Shamira A Perera,1–3 Daniel SW Ting,1,2 Monisha E Nongpiur,1–3 Paul T Chew,3 Maria Cecilia D Aquino,3 Chelvin CA Sng,3 Sue-Wei Ho,1,2 Tin Aung1–3 1Singapore Eye Research Institute, Singapore; 2Singapore National Eye Centre, Singapore; 3Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Purpose: To investigate the efficacy and safety of a punctum plug-based sustained drug release system for a prostaglandin analog, travoprost (OTX-TP), for intraocular pressure (IOP) ­reduction in an Asian population. Methods: This is an initial feasibility, prospective, single-arm study involving 26 eyes and a bioresorbable punctum plug containing OTX-TP. An OTX-TP was placed in the vertical portion of the superior or inferior canaliculus of patients with primary open-angle glaucoma or ocular hypertension. The main outcome measure was the IOP-lowering efficacy of OTX-TP at 3 (8 am) and 10, 20, and 30 days (8 am, 10 am, and 4 pm), compared to baseline. Results: A total of 26 OTX-TP were inserted for 17 subjects. The mean (standard deviation) age was 57.2 (13.8) years. At 10 days, all plugs were still present, and the IOP reduction from baseline was 6.2 (23%), 5.4 (21%), and 7.5 mmHg (28%) at 8 am, 10 am, and 4 pm, respectively. At 10 days, the mean IOP (standard error of mean) was 21.2 (1.2), 20.4 (0.8), and 19.7 (1.0) at 8 am, 10 am, and 4 pm, respectively, showing no discernible IOP trend during the course of the day. At 30 days, plug retention had declined to 42%, and the overall IOP reduction had decreased to 16%. Conclusion: The sustained-release OTX-TP is able to reduce IOP by 24% (day 10) and 15.6% (day 30), respectively. It is a potentially well-tolerable ocular hypotensive for glaucoma patients with a history of poor compliance. Keywords: ocular hypertension, travoprost, bioresorbable, punctum plug, glaucoma, Asian
format article
author Perera SA
Ting DSW
Nongpiur ME
Chew PT
Aquino MCD
Sng CCA
Ho SW
Aung T
author_facet Perera SA
Ting DSW
Nongpiur ME
Chew PT
Aquino MCD
Sng CCA
Ho SW
Aung T
author_sort Perera SA
title Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
title_short Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
title_full Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
title_fullStr Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
title_full_unstemmed Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
title_sort feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an asian population
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/cf4746c7dc064d499a05bfedfcd92e62
work_keys_str_mv AT pererasa feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT tingdsw feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT nongpiurme feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT chewpt feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT aquinomcd feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT sngcca feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT hosw feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
AT aungt feasibilitystudyofsustainedreleasetravoprostpunctumplugforintraocularpressurereductioninanasianpopulation
_version_ 1718401886144430080